Showing results (31-40 of 53) with videos related to

Sort By:
Pageof 6
Clinical Endocrinology|May 1, 1996
131I-6 beta-iodomethylnorcholesterol scintigraphy: an assessment of its role in the investigation of adrenocortical incidentalomasS Bardet, V Rohmer, A Murat, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|November 4, 2014
Genome-wide paternal uniparental disomy as a cause of Beckwith-Wiedemann syndrome associated with recurrent virilizing adrenocortical tumorsF Bertoin, E Letouzé, P Grignani, et al.
European Journal of Endocrinology|March 5, 2014
Patients lost to follow-up in acromegaly: results of the ACROSPECT studyB Delemer, Ph Chanson, L Foubert, et al.
The Journal of Clinical Endocrinology and Metabolism|March 23, 2016
Deletion of CPEB1 Gene: A Rare but Recurrent Cause of Premature Ovarian InsufficiencyC Hyon, L Mansour-Hendili, S Chantot-Bastaraud, et al.
The Journal of Clinical Endocrinology and Metabolism|March 28, 2008
Fertility and obstetrical complications in women with LMNA-related familial partial lipodystrophyM C Vantyghem, D Vincent-Desplanques, F Defrance-Faivre, et al.
Journal of Endocrinological Investigation|December 26, 2025
Safety and glycemic outcomes of DBLG1 coupled to the DANA-i pump in adults and adolescents with type 1 diabetes mellitus. The SP8 trialSylvia Franc, Y Reznik, C Amadou, et al.
Endocrine|June 21, 2020
Discordant biological parameters of remission in acromegaly do not increase the risk of hypertension or diabetes: a study with the Liege Acromegaly Survey databaseV Amodru, P Petrossians, A Colao, et al.
European Journal of Endocrinology|December 24, 2016
Cabergoline for Cushing's disease: a large retrospective multicenter studyA Ferriere, C Cortet, P Chanson, et al.
European Journal of Endocrinology|November 16, 2011
Adrenal involvement in MEN1. Analysis of 715 cases from the Groupe d'etude des Tumeurs Endocrines databaseB Gatta-Cherifi, O Chabre, A Murat, et al.
European Journal of Endocrinology|January 20, 2017
A multivariable prediction model for pegvisomant dosing: monotherapy and in combination with long-acting somatostatin analoguesS E Franck, T I M Korevaar, P Petrossians, et al.
Pageof 6